| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$179,101,866 |
|
|
|
Indirect Value
|
$415,833,338 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$594,935,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
7
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 48.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-06-13 |
4 |
A |
$16.27 |
$5,999,996 |
I/I |
368,720 |
429,912 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-11-17 |
4 |
A |
$19.56 |
$6,000,014 |
I/I |
306,710 |
102,236 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-03-27 |
4 |
B |
$25.72 |
$6,249,986 |
I/I |
243,001 |
243,001 |
2.64 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$16.50 |
$6,999,997 |
D/D |
424,178 |
2,063,458 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2015-12-07 |
4 |
B |
$30.69 |
$7,289,642 |
I/I |
237,525 |
6,483,692 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-03-20 |
4 |
B |
$6.06 |
$7,704,901 |
I/I |
1,264,657 |
6,328,853 |
2.25 |
- |
|
| AQB |
Aquabounty Technologies, ... |
10% Owner |
– – • |
2020-02-13 |
4 |
B |
$1.50 |
$7,762,500 |
I/I |
5,175,000 |
5,175,000 |
1.5 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-28 |
4 |
S |
$18.02 |
$7,789,127 |
I/I |
(432,249) |
1,897,610 |
0 |
- |
|
| AQB |
Aquabounty Technologies, ... |
10% Owner |
– – • |
2020-08-11 |
4 |
B |
$2.50 |
$10,000,000 |
I/I |
4,000,000 |
9,175,000 |
1.5 |
% |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2018-01-19 |
4 |
B |
$12.50 |
$12,500,000 |
I/I |
1,000,000 |
7,782,622 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-22 |
4 |
S |
$17.49 |
$13,675,099 |
I/I |
(781,881) |
2,430,247 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-12-29 |
4 |
A |
$11.33 |
$14,686,410 |
I/I |
1,288,632 |
886,491 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2015-01-27 |
4 |
B |
$27.00 |
$15,000,012 |
I/I |
555,556 |
5,483,957 |
2.64 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$16.50 |
$18,000,003 |
I/I |
1,090,744 |
24,240 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2023-01-27 |
4 |
B |
$1.75 |
$19,999,999 |
I/I |
11,428,571 |
31,129,164 |
2.25 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-05-30 |
4 |
B |
$9.17 |
$32,095,000 |
I/I |
3,500,000 |
3,500,000 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-01-31 |
4 |
B |
$5.86 |
$34,999,999 |
I/I |
5,972,696 |
182,200 |
2.64 |
% |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-07-17 |
4 |
B |
$22.00 |
$49,500,000 |
I/I |
2,250,000 |
2,250,000 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2011-04-12 |
4 |
D |
$30.00 |
$69,800,610 |
D/D |
(2,326,687) |
0 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2018-07-03 |
4 |
B |
$13.37 |
$99,999,992 |
I/I |
7,479,431 |
15,937,319 |
2.64 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2011-04-12 |
4 |
D |
$30.00 |
$260,525,850 |
I/I |
(8,684,195) |
0 |
0 |
- |
|
271 Records found
|
|
Page 11 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
